Transfection of MS-36 melanoma cells with gef gene inhibits proliferation and induces modulation of the cell cycle

Cancer Science

Volumn 94, Issue 6, 2003, Pages 564-568

  Boulaiz, Houria ^a   Prados, José ^a   Marchal, Juan Antonio ^b   García, Ángel Miguel ^c   Álvarez, Luis ^a   Melguizo, Consolación ^d   Carrillo, Esmeralda ^b   Ramos, Juan Luis ^e   Aránega, Antonia ^a  

^a UNIVERSITY OF GRANADA   (Spain)

^b UNIVERSITY OF JAÉN   (Spain)

^c Virgen de Las Nievas Hospital   (Spain)

^d UNIVERSITY OF ALMERÍA   (Spain)

^e CSIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

7 AMINODACTINOMYCIN; AMINO ACID; ANNEXIN; ANTIBIOTIC G 418; ANTINEOPLASTIC AGENT; DEXAMETHASONE; DNA; FLUCYTOSINE; FLUOROURACIL; GANCICLOVIR; MEMBRANE PROTEIN; PRODRUG; PROTEIN GEF; RNA; TRANSCRIPTION FACTOR E2F; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER INHIBITION; CANCER THERAPY; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL PROLIFERATION; CELL SIZE; CELL STRUCTURE; CONTROLLED STUDY; EXPRESSION VECTOR; FILOPODIUM; GENE THERAPY; HUMAN; HUMAN CELL; MELANOMA CELL; MEMBRANE STRUCTURE; NONVIRAL GENE DELIVERY SYSTEM; PRIORITY JOURNAL;

EID: 0038301897     PISSN: 13479032     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2003.tb01483.x     Document Type: Article

References (32)

1. Freeman SM. Suicide gene therapy. Adv Exp Med Biol 2000; 465: 411-22.
2. Kirn D, Niculescu-Duvaz I, Hallden G, Springer CJ. The emerging fields of suicide gene therapy and virotherapy. Trends Mol Med 2002; 8: 68-73.
3. Smythe WR. Prodrug/drug sensitivity gene therapy: current status. Curr Oncol Rep 2000; 2: 17-22.
4. Greco O, Dachs GU. Genes directed enzyme/prodrug therapy of cancer: historical appraisal and future perspectives. J Cell Physiol 2001; 187: 22-36.
5. Spencer DM. Development in suicide genes for preclinical and clinical application. Curr Opin Mol Ther 2000; 2: 433-40.
6. Dilber MS, Gahrton G. Suicide gene therapy: possible application in hematopoietic disorders. J Intern Med 2001; 249: 359-67.
7. Crystal RG. In vivo and ex vivo gene therapy strategies to treat tumors using adenovirus gene transfer vectors. Cancer Chemother Pharmacol 1999; 43: 90-9.
8. Lal S, Lauer UM, Niethammer D, Beck JF, Schlegel PG. Suicide genes: past, present and future perspectives. Immunol Today 2000; 21: 48-54.
9. Farquhar D, Pan BF, Sakurai M, Ghosh A, Mullen CA, Nelson JA. Suicide gene therapy using E. coli beta-galactosidase. Cancer Chemother Pharmacol 2002; 50: 65-70.
10. Pietersen A, Noteborn HM. Apoptin. Adv Exp Med Biol 2000; 465: 153-61.
11. Gerdes K, Poulsen LK, Thisted T, Nielsen AK, Martinussen J, Anderssen PH. The hok killer gene family in Gram negative bacteria. New Biol 1990; 2: 946-56.
12. Poulsen LK, Refn A, Malin S, Andersson P. Topographic analysis of the toxic gef protein from E. coli. Mol Microbiol 1991; 5: 1639-48.
13. Molin SL, Boe LB, Jensen CS, Kristensen M, Givskov M, Ramos JL, Bej AK. Suicidal genetic elements and their use in biological containment of bacteria. Annu Rev Microbiol 1993; 47: 139-66.
14. Ronchel M, Ramos JL. Dual system to reinforce biological containment of recombinant bacteria designed for rhizomediation. Appl Environ Microbiol 2001; 67: 2649-56.
15. Sambrook J, Fritsch EF, Maniatis T. In vitro amplification of DNA by the polymerase chain reaction. In: Nolan C, editor. Molecular cloning. A laboratory manual. New York: Cold Spring Harbor Laboratory Press; 1989. p. 14.18-9.
16. Prados J, Melguizo C, Marchal JA, Vélez C, Álvarez L, Aránega A. Multidrug resistance phenotype in the RMS-GR human rhabdomyosarcoma cell line obtained after polychemotherapy. Jpn J Cancer Res 1999; 90: 788-93.
17. Prados J, Melguizo C, Aránega AE, Escobar-Jiménez F, Cobo V, González R, Aránega A. Circulating alpha-actin in non-insulin-dependent diabetics with autonomic dysfunction. Int J Cardiol 1995; 51: 127-30.
18. Villalobos M, Olea N, Brotons JA, Olea-Serrano MF, Ruiz de Almodóvar JM, Pedraza V. The E-Screen assay: a comparison of different MCF-7 cell stocks. Env Health Perspect 1995; 9: 844-9.
19. Philpott NJ, Turner AJC, Scopes J, Westby M, Marsh JCW, Gordon-Smith EC, Dalgleish AG, Gibson FM. The use of 7-amino actinomycin D in identifying apoptosis: simplicity of use and broad spectrum of application compared with other techniques. Blood 1996; 87: 2244-51.
20. Zhuang SM, Shvarts A, Ormondt HV, Jochemsen AG, Vander EB, Noteborn M. Apoptin, a protein derived from chicken anemia virus, induces p53-independent apoptosis in human osteosarcoma cells. Cancer Res 1995; 55: 486-9.
21. Paulus W, Baur I, Oberer DM, Breakefield XO, Reeves AA. Regulated expression on the diphtheria toxin A gene in human glioma cells using prokaryotic transcriptional control elements. J Neurosurg 1997; 87: 89-95.
22. Martin V, Cortés ML, De Felipe P, Farsetti A, Calcaterra NB, Izquierdo M. Cancer gene therapy by thyroid hormone-mediated expression of toxin genes. Cancer Res 2000; 60: 218-24.
23. Jain KK. Use of bacteria as anticancer agents. Expert Opin Biol Ther 2001; 1: 291-300.
24. Gerdes K, Bech FW, Jorgensen ST, Lobner-Olesen A, Rasmussen PB, Atlung T, Boe L, Karlstom O, Malin S, Von Meyenburg K. Mechanism of postsegregational killing by the hok gene product of the parB system of plasmid R1 and its homology with the relf gene product of the E. Coli relB operon. EMBO J 1986; 5: 2023-9.
25. Ono K, Akimoto S, Ohnishi Y. Nucleotide sequence of the pnd gene in plasmid R483 and role of the pnd gene product in plasmolysis. Microbiol Immunol 1987; 31: 1071-83.
26. Wei SJ, Chao Y, Hung YM, Lin WC, Yang DM, Shih YL, Ch'ang LY, Whang-Peng J, Yang WK. S and G2 phase cell cycle arrests and apoptosis induced by ganciclovir in murine melanoma cells transduced with herpes simplex virus thymidine kinase. Esp Cell Res 1998; 241: 66-75.
27. Martín V, Cortés ML, de Felipe P, Farsetti A, Calcaterra NB, Izquierdo M. Cancer gene therapy by thyroid hormone-mediated expression of toxin genes. Cancer Res 2000; 60: 3218-24.
28. Miki K, Al-Refaie W, Xu M, Jiang P, Tan Y, Bouvet M, Zhao M, Gupta A, Chishima T, Shimada H, Makuuchi M, Moossa AR, Hoffman M. Methioninase gene therapy of human cancer cells is synergistic with recombinant methioninase treatment. Cancer Res 2000; 60: 2696-702.
29. Dong YB, Yang HL, Elliot MJ, Liu TJ, Stilwell A, Atienza C, McMaster KM. Adenovirus-mediated E2F-1 gene transfer efficiently induces apoptosis in melanoma cells. Cancer 1999; 86: 2021-33.
30. Niu G, Heller R, Catlett-Falcone R, Coppola D, Jaroszeski M, Dalton W, Jove R, Yu H. Gene therapy with dominant-negative Stat3 suppresses growth of the murine melanoma B16 tumor in vivo. Cancer Res 1999; 59: 5059-63.
31. Jaine KK. Use of bacteria as anticancer agents. Expert Opin Biol Ther 2001; 1: 291-300.
32. Katabi M, Yuan S, Chan H, Galipeau J, Batist G. The nonapoptotic pathway mediating thymidine kinase/ganciclovir toxicity is reduced by signal from adenovirus type 5 early region 4. Mol Ther 2002; 5: 170-6.